Background: Dysarthria in neurological disorders can have psychosocial consequences. The dysarthric speaker's perspective towards the disorder's psychosocial impact is essential in its global assessment and management. For such purposes, assessment tools such as the Dysarthria Impact Profile (DIP) are indispensable. Objective: We aimed to confirm the relevance of using the DIP to quantify the psychosocial consequences of dysarthria in neurological diseases. Methods: We studied 120 participants, 15 healthy controls and 105 patients with different kinds of dysarthria induced by several neurological disorders (Parkinson's disease [PD], Huntington's disease, dystonia, cerebellar ataxia, progressive supranuclear palsy [PSP], multiple system atrophy, lateral amyotrophic sclerosis). All participants underwent a cognitive evaluation and a speech intelligibility assessment and completed three self-reported questionnaires: the 36-Item Short Form Health Survey, the Voice Handicap Index (VHI), and the DIP. Results: The psychometric properties of the DIP were confirmed, including internal consistency (α = 0.93), concurrent validity (correlation with the VHI: r = -0.77), and discriminant validity (accuracy = 0.93). Psychosocial impact of dysarthria was revealed by the DIP for all patients. Intelligibility loss was found strongly correlated with the psychosocial impact of dysarthria: for a similar level of intelligibility impairment, the DIP total score was similar regardless of the pathological group. However, our findings suggest that the psychosocial impact measured by the DIP could be partially independent from the severity of dysarthria (indirectly addressed here via speech intelligibility): the DIP was able to detect patients without any intelligibility impair- ment, but with a psychosocial impact. Conclusions: All patients reported a communication complaint, attested by the DIP scores, despite the fact that not all patients, notably PD, ataxic, and PSP patients, had an intelligibility deficit. The DIP should be used in clinical practice to contribute to a holistic evaluation and management of functional communication in patients with dysarthria.
sive supranuclear palsy [PSP] , multiple system atrophy, lateral amyotrophic sclerosis). All participants underwent a cognitive evaluation and a speech intelligibility assessment and completed three self-reported questionnaires: the 36-Item Short Form Health Survey, the Voice Handicap Index (VHI), and the DIP. Results: The psychometric properties of the DIP were confirmed, including internal consistency (α = 0.93), concurrent validity (correlation with the VHI: r = -0.77), and discriminant validity (accuracy = 0.93). Psychosocial impact of dysarthria was revealed by the DIP for all patients. Intelligibility loss was found strongly correlated with the psychosocial impact of dysarthria: for a similar level of intelligibility impairment, the DIP total score was similar regardless of the pathological group. However, our findings suggest that the psychosocial impact measured by the DIP could be partially independent from the severity of dysarthria (indirectly addressed here via speech intelligibility): the DIP was able to detect patients without any intelligibility impair-
Introduction
Dysarthria is common in neurological movement disorders and represents 53% of acquired communication impairments [1] . Six kinds of dysarthria were initially described by Darley et al. [2] (Fig. 1 ). Hypokinetic and hyperkinetic dysarthrias result from subcortical dysfunctions respectively associated to reduced and increased movements. Ataxic dysarthria is associated with cerebellar dysfunctions. Bilateral upper motoneuron alterations can induce spastic dysarthria, while the dysfunction of the final motor pathway can lead to flaccid dysarthria. A mixed dysarthria results from multiple brain alterations. Duffy [1] introduced two additional dysarthria types resulting from a unilateral upper motor deficit and from undetermined etiology. Dysarthria is generally assessed from a pathophysiological perspective, in that a specific disease is viewed to be the cause of a particular speech impairment. During a routine consultation, neurologists frequently rely on rating speech intelligibility, and if required, further clinical assessments and acoustic analyses can provide additional information, such as objective measures on laryngeal and supra-laryngeal articulations.
Dysarthria leads to communication deficits, which frequently induce social isolation [3] , a decrease in quality of life [4] , and alterations in daily-living activities [5] . Such deficits also increase the risk of developing psychoemotional disorders such as depression [6] , or even cognitive deterioration [7] . Yet, the majority of assessments dedicated to speech/voice impairments are based on the symptoms themselves [8, 9] , and not on the symptoms' consequences. A "biomedical model of illness is inadequate in understanding the full impact of communication disorders" and "psychosocial factors should be considered" [10] . This practice leaves unanswered the symptoms' effects on quality of life, despite quality of life being dependent on those consequences that affect physical, psychological, and social components [11] . A method of bridging the gap between symptom consequences on quality of life is to monitor patient-reported outcomes (PROs). PROs appear as particularly important contributions to clinical practice, especially because they report functional facts that are not systematically in agreement with the degree of severity of the symptom [12] . As stated by the PRO Harmonization Group (www.eriqa-project. com), PROs allow clinicians (1) to better acquaint themselves with symptom consequences, (2) to assess the relevance of a treatment, (3) to guide medical choices, and (4) to improve the interpretation of clinical outcomes [13] .
Among the assessments of PROs is the Dysarthria Impact Profile (DIP), which was developed and validat- The different types of dysarthria according to the location of pathophysiological dysfunctions (based on previous dysarthria classification). Hypokinetic and hyperkinetic dysarthrias are associated to basal ganglia dysfunctions, while ataxic dysarthria results from cerebellar dysfunction. Unilateral upper motor neuron (UUMN), spastic, and flaccid dysarthrias are the sequel of pyramidal tract dysfunctions (upper motor neuron and unilateral for UUMN, upper motor neuron and bilateral for spastic dysarthria, and lower motor neuron for flaccid dysarthria). Not mentioned in this representation: mixed dysarthrias (resulting from multiple subcortical/cortical lesions) and dysarthria of undetermined etiology.
DOI: 10.1159/000499627 ed in English, with patients presenting with different kinds of dysarthria [14] . Its adaptations in French [15] and European Portuguese [16] have been performed, but only for hypokinetic dysarthria in Parkinson's disease (PD) patients. We propose here a revised French version for which all previously acknowledged limitations [15] were overcome. The objectives of the present study were to confirm the psychometric properties of this revised version of the French DIP with patients presenting with different kinds of dysarthria, and to further demonstrate the relevance of using psychosocial indicators as part of the global assessment and management of dysarthria.
Materials and Methods

Participants
We recruited 105 patients pertaining to seven pathological groups (15 per group) and associated with five kinds of dysarthria, including hypokinetic (PD), hyperkinetic (Huntington's disease [HD], dystonia), ataxic (degenerative cerebellar ataxia), and mixed (progressive supranuclear palsy [PSP], multiple system atrophy [MSA] , amyotrophic lateral sclerosis [ALS] ). The only inclusion/exclusion criterion was that patients had had no neurostimulation and that they were able to understand and complete the questionnaires. The patients, under usual medication, were recruited during routine outpatient visits to Neurological and ENT wards, based on neurological diagnosis and not on the presence of dysarthria. The local Ethics Committee Review Board ensured that all ethics criteria were granted in this research, which was conducted after informed consent of the patients. A group of 15 healthy controls (HC) was also recruited. Demographic and clinical characteristics of participants are summarized in Table 1 .
Acoustic Measures and Clinical Assessments
Speech intelligibility was assessed by a speech pathologist on the basis of speech records provided by the intelligibility section of the Frenchay Dysarthria Assessment (FDA-2). The participants read ten words and ten sentences, randomly and blindly chosen from a list of 116 words and 50 sentences. Intelligibility scores were reported as percentages of correctly transcribed items [17] .
Among acoustic parameters, means and standard deviations of fundamental frequency (F0) and speech loudness (SPL, sound pressure level) were extracted from the sentences read by the patients. These measures were focused on in our study since monopitch and monoloudness are particular deficits often displayed in dysarthric speech.
The Montreal Cognitive Assessment (MoCA [18] ) was performed to detect any cognitive impairment.
The 36-Item Short Form Health Survey (SF-36 [19] ) is a nonspecific quality of life self-questionnaire, which examines four physical and four mental subdomains. Each subdomain is scored from 0 (maximal disturbance) to 100 (normal).
The Voice Handicap Index (VHI [8] ) is often considered as the gold standard for voice self-perception [9] . It includes 30 items split into three domains: physical, functional, emotional. Each item is scored from 0 to 4: the higher the score, the higher the degree of perceived handicap.
The DIP [14] [15] [16] is composed of four numerical subscales (A: "the effect of dysarthria on me as a speaker;" B: "accepting my dysarthria;" C: "how I feel others react to my speech;" D: "how dysarthria affects my communication with others"). Each item is scored from 1 (major impact) to 5 (no impact): the lower the score, the higher the degree of psychosocial handicap. The last subscale (part E) was not included in this analysis since it is a qualitative section that does not provide any numerical score. Statistical Analyses All statistical analyses were performed with R software. We calculated Cronbach's α to assess the internal consistency of the DIP (an adequate consistency would correspond to a coefficient of at least 0.70). We performed Pearson's correlations (after Holm's correction) between the scales in order to estimate the concurrent validity of the DIP, and receiver operating characteristic (ROC) analyses between (1) HC and all patients to determine discriminant validity (sensitivity, specificity, accuracy [area under the curve], power, and cut-off) of the DIP, and (2) for each items of the DIP, between HC and patients to determine discriminant items and between each group of patients and the other patients to determine any specificity of each disease. Also, Hedges' g effect sizes were calculated to compare HC to patients. Considering the Values in italics indicate that (A) Cronbach' α was insufficient (α < 0.7) and (B) correlation was not significant (p > 0.05) after Holm's correction. ALS, amyotrophic lateral sclerosis; DIP, Dysarthria Impact Profile (A: "the effect of dysarthria on me as a speaker"; B: "accepting my dysarthria number of analyses performed and the rather small number of participants per group, we considered as meaningful only large effect sizes (g ≥ 0.8). Finally, we performed one linear regression to determine the influence of both intelligibility and the pathological group on the DIP total score.
Results
Psychometric Properties of the DIP
For the total DIP score, internal consistency was confirmed for all groups (α > 0.7; Table 2A ); it was also confirmed for the four subscales when we considered all participants together: A (α = 0.81), B (α = 0.71), C (α = 0.79), and D (α = 0.85). The correlations we generated demonstrated that the DIP had good construct validity (Table  2B) Table  2C ). The cut-off of the total DIP score allowed us to determine the proportion of patients who had a communication complaint: 66.6% of PD patients, 73.3% of ataxic patients, 80% of dystonic patients, 86.6% of HD patients, 93.3% of MSA patients, 100% of PSP patients, and 100% of ALS patients (Fig. 2) .
Patient Phenotypes according to the Communication Complaint
Patient phenotypes were ranked according to the total DIP score, from the smallest to the highest complaint: PD . Hedges' g effect sizes between patients and HC for the DIP and VHI subscales demonstrated that all patients reported a dysarthria complaint (g > 0.8). However, PD, ataxic, and PSP patients did not show any decrease of intelligibility (g < 0.8). Most of the items were discriminant between each group of patients and the controls (Fig. 3, upper part of the right panels). No items reached the threshold of accuracy between PD patients and other patients, while only one item was significant for ataxic patients (C13; p = 0.008) and dystonic patients (D04; p = 0.027). For HD, PSP, and MSA patients, between 4 and 5 items were significantly discriminant from other patients (Fig. 3) . Lastly, A02  A03  A04  A05  A06  A07  A08  A09  A10  A11  A12  B01  B02  B03  B04  B05  B06  B07  B08  B09  B10  C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11  C12  C13  C14  D01  D02  D03  D04  D05  D06  D07  D08  D09  D10  D11 A02  A03  A04  A05  A06  A07  A08  A09  A10  A11  A12  B01  B02  B03  B04  B05  B06  B07  B08  B09  B10  C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11  C12  C13  C14  D01  D02  D03  D04  D05  D06  D07  D08  D09  D10  D11 A02  A03  A04  A05  A06  A07  A08  A09  A10  A11  A12  B01  B02  B03  B04  B05  B06  B07  B08  B09  B10  C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11  C12  C13  C14  D01  D02  D03  D04  D05  D06  D07  D08  D09  D10  D11 A01  A02  A03  A04  A05  A06  A07  A08  A09  A10  A11  A12  B01  B02  B03  B04  B05  B06  B07  B08  B09  B10  C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11  C12  C13  C14  D01  D02  D03  D04  D05  D06  D07  D08  D09  D10  D11 for ALS patients, eleven items, ranging from A06 to D12 were significant (p < 0.05). We also observed that both the pathological group (F (7; 104) = 12.97; p < 0.001) and the intelligibility score (F (1; 104) = 6.87; p = 0.01) had an effect on the total DIP score, but without any significant interaction (F (7; 104) = 0.97; p = 0.45).
Discussion
All patients reported a communication complaint, regardless of the presence of speech impairment clinically estimated via speech intelligibility. Interestingly, PD, ataxic, and PSP patients did not show any deficit of speech intelligibility. Our study suggests that it would be relevant to take into account psychosocial indicators of dysarthria in patients with neurodegenerative disorders.
Psychometric Confirmation of the DIP
Our study confirmed the psychometric properties of the revised French version of the DIP, thus validating the use of this self-questionnaire for estimating the impact of dysarthria in patients with several neurodegenerative disorders. The original DIP was administered to 31 people with different types of dysarthria [14] , and consecutive adaptations in other languages confirmed its relevance for the management of PD [15, 16] . Our results go one step beyond the use of the DIP as part of the clinical assessment of dysarthria, providing such evidence from a protocol that overcame the limitations of the previous version. Notably, we included a larger number of participants with different diseases and different kinds of dysarthria, we rephrased unclear statements, and we perfected the formal presentation of the questionnaire (online supplementary material, see www.karger.com/ doi/10.1159/000499627). In addition, the new formal organization of the DIP makes it easy to quickly determine whether the questionnaire has been properly completed: answering the questionnaire requires alternating between the responses "agree" and "disagree." As suggested by the absence of correlation between the DIP and the MoCA, the DIP score is either not or only weakly driven by the cognitive status of the patients. The DIP can thus be administered to patients with mild cognitive impair- A02  A03  A04  A05  A06  A07  A08  A09  A10  A11  A12  B01  B02  B03  B04  B05  B06  B07  B08  B09  B10  C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11  C12  C13  C14  D01  D02  D03  D04  D05  D06  D07  D08  D09  D10  D11 A02  A03  A04  A05  A06  A07  A08  A09  A10  A11  A12  B01  B02  B03  B04  B05  B06  B07  B08  B09  B10  C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11  C12  C13  C14  D01  D02  D03  D04  D05  D06  D07  D08  D09  D10  D11 A01  A02  A03  A04  A05  A06  A07  A08  A09  A10  A11  A12  B01  B02  B03  B04  B05  B06  B07  B08  B09  B10  C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11  C12  C13  C14  D01  D02  D03  D04  D05  D06  D07  D08  D09  D10  D11 ment, but we recommend that patients with higher cognitive impairments fill out the DIP with the help of a clinician or a caregiver.
Speech Intelligibility Is Not Functional Communication
Our findings suggest that intelligibility loss is crucially correlated to the psychosocial impact of dysarthria. This means that, for a similar level of intelligibility impairment, the DIP total score is similar regardless of the pathological group. Nevertheless, the intelligibility score remains insufficient to address the psychosocial impact of dysarthria for at least two reasons: (1) the intelligibility score explained only 18.5% of the total DIP score (determination coefficient; r 2 ); (2) two patient groups (PD and ataxia) displayed a significant DIP score (in comparison to the controls), but a level of speech impairment not so significant to impair intelligibility. Our findings suggest that the psychosocial impact measured by the DIP could be partially independent from the severity of dysarthria (indirectly addressed here via speech intelligibility): the DIP was able to detect patients without any intelligibility impairment, but with a psychosocial impact. This might be related to the observed independence between the perspective of the patients and those of the caregivers on communication effectiveness [20] . Thus, the assessment of speech intelligibility, which is central in the neurological investigation of dysarthria, remains insufficient to address the patient's complaints and could not represent per se the sole indicator of speech evaluation and management in clinical routine [21] . Indeed, one study showed that the majority of patients with Parkinsonian syndromes reported a communication impairment, even if some of them remained intelligible [22] . It is necessary to consider that communication ability depends on intelligibility, but also on how patients feel about the perception of others [22] . For example, based on a literature review, only 5% of scientific research in 2007 focused on psychosocial aspects of dysarthria [23] . The ROC analysis of DIP items demonstrated (especially for PD, ataxic, and PSP patients who had no significant intelligibility deficit) that psychosocial consequences of dysarthria could be due to the reactions of others ("I never feel that others laugh or make fun of my speech" [C13, significant for ataxic patients]). The analysis also showed that psychosocial consequences could lower patients' self-perception ("I am as confident now as I was before I had a speech problem" [A05, significant for PSP patients]) and contribute to the isolation of patients ("Although I have difficulty speaking I do not avoid communicating with people I know" [D01, significant for PSP patients]; "My social life has not changed as a result of my dysarthria" [D02, significant for PSP patients]). Thus, our results are in agreement with a previous qualitative report that focused on acquired dysarthria and for which several themes were frequently mentioned by patients: "communication has changed," "people treat me differently," "dysarthria resulting in negative emotions," "barriers to communicate," "life is different now" [24] . So far, this statement remains topical and underlies the fact that dysarthria is a functional symptom which is still undervalued.
Enhancing Clinical Assessment and Management of Dysarthria with the PRO
On the exclusive basis of the neurological assessment, patients with dysarthria are generally referred to a speech therapist/pathologist only when intelligibility is significantly impaired. This might explain the gap between the number of patients with dysarthria complaints and the number of patients who have received speech therapy. For example, it has been reported that 70-90% of PD patients complain about speech impairment; 29% of the patients reported that dysarthria had a significant impact in their life, but only 3% accessed speech therapy [25] , though these numbers have recently improved [26] . Speech therapy can improve communication abilities and reduce social isolation [27] . Thus, patients should be seen earlier than they are currently to help reduce the psychosocial impact. Indeed, a recent study on PD reported that a longer disease duration is associated with a lower speech therapy efficacy [28] . The ROC analyses we conducted provided a cut-off of the DIP, below which the complaint of the patients should be further discussed with them and possibly, the patients could be referred to a speech/language therapist for additional counselling: clinicians could use the DIP as a tool to precisely estimate the psychosocial consequences of dysarthria [29] . Furthermore, to better manage dysarthria, it is crucial to include patient-reported difficulties in functional communication [26] as indicators of both dysarthria's psychosocial impact [29] and speech therapy management [27, 30, 31] . Thus, using the DIP as a psychosocial indicator can be useful to correctly adjusting a speech rehabilitation program [32, 33] .
Limitations of the Study
Our study included some limitations. First, our patient groups included an amount of intra-group heterogeneity in terms of symptom expression, etiology, disease severity, disease duration, etc. However, our objective was to DOI: 10.1159/000499627 highlight the relevance of using the DIP with patients suffering from different neurodegenerative diseases, with no specific criteria of exclusion (except other neurological or psychiatric history). Second, we did not have access to information related to social environment, professional context, and even cultural information. These data could be of importance to better identify complaints of communication and have to be considered in clinical practice on a patient-by-patient individual basis. Finally, we did not evaluate depression, apathy, or anhedonia, which could contribute to altering functional communication.
Additional and specific studies are still required to overcome these limitations.
Conclusion
Dysarthria is a frequent and debilitating symptom of neurological disorders, and from the patient perspective, it is a multidimensional symptom, impacting also social and emotional daily-living components [24] . However, the proportion of patients who access speech therapy is significantly lower than the proportion of patients who complain about communication. Integrating an additional tool such as the DIP, which provides the patient's point of view, is important to better identify patients with a communication complaint, especially when these patients remain intelligible. Thus, communication ought to be assessed from a holistic perspective, including both professional expertise and the patient's feelings.
